Early Concomitant Vedolizumab As First-Line for Immune-Related Colitis Therapy Trial
Latest Information Update: 27 Feb 2025
At a glance
- Drugs Vedolizumab (Primary) ; Cotrimoxazole; Methylprednisolone; Prednisone
- Indications Colitis; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms EVITA
Most Recent Events
- 27 Feb 2025 New trial record